Early management of atrial fibrillation: from imaging to drugs to ablation

被引:12
|
作者
Shah, Ashok J. [1 ]
Liu, Xingpeng [1 ]
Jadidi, Amir S. [1 ]
Haissaguerre, Michel [1 ]
机构
[1] Univ Hosp Bordeaux, Hop Cardiol Haut Leveque, F-33604 Pessac, France
关键词
CONGESTIVE-HEART-FAILURE; PULMONARY VEIN ISOLATION; TACHYCARDIA-INDUCED CARDIOMYOPATHY; CONVERTING ENZYME-INHIBITION; LONG-LASTING PERSISTENT; ARTERY-BYPASS SURGERY; 30-YEAR FOLLOW-UP; RHYTHM-CONTROL; SINUS RHYTHM; RISK-FACTORS;
D O I
10.1038/nrcardio.2010.49
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) is the most common cardiac arrhythmia, and is responsible for the highest number of rhythm-related disorders and cardioembolic strokes worldwide. Early management of this condition will lower the risk of AF-associated morbidity and mortality. Targeted drug therapy has an important role in preventing the progression of AF through modification of the substrate. Discovery of the role of pulmonary veins as a trigger has been an important breakthrough, leading to the development of pulmonary vein ablation-an established curative therapy for drug-resistant AF. Identifying the underlying reasons for the abnormal firing of venous cardiomyocytes and the widespread progressive alterations of atrial tissue found in persistent AF are challenges for the future. Novel imaging techniques may help to determine the right time for intervention, provide specific targets for ablation, and judge the efficacy of treatment. If new developments can successfully address these issues, the knowledge acquired as a result will have a vital role in preclinical and early management of AF.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 50 条
  • [21] Catheter Ablation for Atrial Fibrillation
    Thomas, Stuart P.
    Sanders, Prashanthan
    HEART LUNG AND CIRCULATION, 2012, 21 (6-7): : 395 - 401
  • [22] Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter Ablation
    Viles-Gonzalez, Juan F.
    Fuster, Valentin
    Halperin, Jonathan
    Calkins, Hugh
    Reddy, Vivek Y.
    CLINICAL CARDIOLOGY, 2011, 34 (01) : 23 - 29
  • [23] Effect of early catheter ablation of atrial fibrillation in patients with heart failure
    Toth, Patrik
    Arnoth, Bence
    Komlosi, Ferenc
    Szegedi, Nandor
    Sallo, Zoltan
    Perge, Peter
    Osztheimer, Istvan
    Merkely, Bela
    Geller, Laszlo
    Nagy, Klaudia Vivien
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (07) : 1471 - 1479
  • [24] Role of magnetic resonance imaging in atrial fibrillation ablation
    Beinart R.
    Nazarian S.
    Current Treatment Options in Cardiovascular Medicine, 2014, 16 (6)
  • [25] Imaging before and after catheter ablation of atrial fibrillation
    Ohana, M.
    Bakouboula, B.
    Labani, A.
    Jeung, M. -Y.
    El Ghannudi, S.
    Jesel-Morel, L.
    Roy, C.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2015, 96 (11) : 1113 - 1123
  • [26] Atrial Fibrillation Therapy Now and in the Future Drugs, Biologicals, and Ablation
    Woods, Christopher E.
    Olgin, Jeffrey
    CIRCULATION RESEARCH, 2014, 114 (09) : 1532 - 1546
  • [27] Pulsed field ablation for atrial fibrillation - Lessons from magnetic resonance imaging
    Fink, Thomas
    Sciacca, Vanessa
    Neven, Kars
    Didenko, Maxim
    Sommer, Philipp
    Sohns, Christian
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (12): : 1586 - 1594
  • [28] The Role of Left Atrial Imaging in the Management of Atrial Fibrillation
    Walters, Tomos E.
    Ellims, Andris H.
    Kalman, Jonathan M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (02) : 136 - 151
  • [29] Management of Atrial Fibrillation in Patients With Structural Heart Disease
    Darby, Andrew E.
    DiMarco, John P.
    CIRCULATION, 2012, 125 (07) : 945 - 957
  • [30] Management of atrial fibrillation - effect of catheter ablation on mortality?
    Hartmann, Jens
    Gunawardene, Melanie
    Jularic, Mario
    Eickholt, Christian
    Willems, Stephan
    AKTUELLE KARDIOLOGIE, 2021, 10 (03) : 201 - 206